US Patent 9242961 Aurora kinase modulators and method of use
Patent 9242961 was granted and assigned to Amgen on January, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+93 characters)
Article
Patent abstract
The present invention relates to chemical compounds having a general formula I
Edits on 28 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Karina Romero0
Victor J. Cee0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09242961 Aurora kinase modulators and method of use US Patent 9242961 Aurora kinase modulators and method of use
Infobox
Patent Number
092429610
Patent Number
92429610
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
092429610
Date of Patent
January 26, 2016
0Patent Application Number
140457150
Date Filed
October 3, 2013
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09242961 Aurora kinase modulators and method of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09242961
Date of patent
January 26, 2016
Patent application number
14045715
Date Filed
October 3, 2013
Patent primary examiner
Find more entities like US Patent 9242961 Aurora kinase modulators and method of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
